LAVITRANO MARIALUISA

Cordani, N., Mologni, L., Piazza, R., Cogliati, V., Pepe, F., Capici, S., et al. (2023). Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells. In Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX (pp.13-21). AACR [10.1158/1538-7445.SABCS22-P1-13-21]. Dettaglio

Giambra, M., Di Cristofori, A., Conconi, D., Marzorati, M., Redaelli, S., Zambuto, M., et al. (2023). Insights into the Peritumoural Brain Zone of Glioblastoma: CDK4 and EXT2 May Be Potential Drivers of Malignancy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(3) [10.3390/ijms24032835]. Dettaglio

L'Imperio, V., Wulczyn, E., Plass, M., Müller, H., Tamini, N., Gianotti, L., et al. (2023). Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification. JAMA NETWORK OPEN, 6(3) [10.1001/jamanetworkopen.2022.54891]. Dettaglio

Betzler, A., Strobel, H., Abou Kors, T., Ezić, J., Lesakova, K., Pscheid, R., et al. (2023). BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression. CANCERS, 15(1) [10.3390/cancers15010310]. Dettaglio

Ardizzoia, A., Jemma, A., Redaelli, S., Silva, M., Bentivegna, A., Lavitrano, M., et al. (2023). AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(14) [10.3390/ijms241411455]. Dettaglio